Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 9,039 | 7,205 | 7,290 | 1,983 | 1,992 |
Operating Income | -9,039 | -7,205 | -7,290 | -1,983 | -1,992 |
Other Income | 97 | 92 | -49 | 156 | 205 |
Pre-tax Income | -8,942 | -7,113 | -7,339 | -1,827 | -1,787 |
Net Income Continuous | -8,942 | -7,113 | -7,339 | -1,827 | -1,787 |
Net Income | $-8,942 | $-7,113 | $-7,339 | $-1,827 | $-1,787 |
EPS Basic Total Ops | -0.45 | -0.86 | -1.58 | -0.40 | -0.39 |
EPS Basic Continuous Ops | -0.45 | -0.86 | -1.57 | -0.40 | -0.39 |
EPS Diluted Total Ops | -0.45 | -0.86 | -1.58 | -0.40 | -0.39 |
EPS Diluted Continuous Ops | -0.45 | -0.86 | -1.57 | -0.40 | -0.39 |
EPS Diluted Before Non-Recurring Items | -0.45 | -0.86 | -1.54 | -0.40 | -0.39 |
EBITDA(a) | $-9,035 | $-7,146 | $-7,050 | $-1,972 | $-2,032 |